Finemedix Co., Ltd. (KOSDAQ:387570)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,925.00
+25.00 (0.51%)
At close: Aug 11, 2026

Finemedix Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-1,785-1,878-24.151,176239.58-1,410
Depreciation & Amortization
962.94961.79995.65964.01959.62983.4
Loss (Gain) From Sale of Assets
-4.87-4.87180--1,382-10.53
Loss (Gain) From Sale of Investments
-----6.15
Loss (Gain) on Equity Investments
----240-
Stock-Based Compensation
53.577.88106.3817.73--
Provision & Write-off of Bad Debts
133.03144.9664.928.821.39-11.19
Other Operating Activities
-333.98-551.77174.68160.49559.4891.96
Change in Accounts Receivable
32.28-175.8-317.04-472.59-840.73709.22
Change in Inventory
-690.58-1,114-875.32-128.5-686.44-247.65
Change in Accounts Payable
85.66-52.38-27.13-34.8430.31-210.88
Change in Unearned Revenue
--0.17--10.120.1410.15
Change in Other Net Operating Assets
44.63-42.06-107.32-302.9-556.31299.1
Operating Cash Flow
-1,502-2,634170.681,378-1,435210.19
Operating Cash Flow Growth
---87.61%--2.25%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-496.61-852.1-595.45-336.13-691.8-1,086
Sale of Property, Plant & Equipment
7.267.26--3,77010.45
Cash Acquisitions
-----0.88
Divestitures
----200-
Sale (Purchase) of Intangibles
-1-1---2.76-141.92
Investment in Securities
1,464-4,037780.25577.8-1,404-299.48
Other Investing Activities
-17.27-23.9346.6205.092.66-82.86
Investing Cash Flow
956.48-4,907124.91546.761,774-1,599

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
---1,900--
Long-Term Debt Issued
-1,177---1,000
Total Debt Issued
1,1771,177-1,900-1,000
Short-Term Debt Repaid
--400--1,000--
Long-Term Debt Repaid
--480.57-542.68-2,115-1,739-1,693
Total Debt Repaid
-482.33-880.57-542.68-3,115-1,739-1,693
Net Debt Issued (Repaid)
694.88296.64-542.68-1,215-1,739-692.72
Issuance of Common Stock
--9,270---
Other Financing Activities
-30.71-30.71-559.97--8080
Financing Cash Flow
664.17265.938,167-1,215-1,819-612.72

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
30.220.8865.05-6.11-42.3225.71
Miscellaneous Cash Flow Adjustments
00----
Net Cash Flow
148.73-7,2748,528703.97-1,522-1,976

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-1,999-3,486-424.771,042-2,127-875.99
Free Cash Flow Growth
------
Free Cash Flow Margin
-20.28%-36.61%-4.26%10.26%-26.12%-12.08%
Free Cash Flow Per Share
-367.94-641.95-87.93227.36-472.25-269.47
Levered Free Cash Flow
-1,779-2,930-938.72406.62-2,159-1,161
Unlevered Free Cash Flow
-1,721-2,872-865.84530.88-1,999-1,012

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
63.2187.69126.41102.3960.04183.99
Cash Income Tax Paid
169.73237.7642.6943.39-0.613.94
Change in Working Capital
-528.02-1,384-1,327-948.95-2,053559.95